Tenaya Therapeutics to Participate in Upcoming Investor Conferences
February 07 2023 - 5:17PM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage
biotechnology company with a mission to discover, develop and
deliver potentially curative therapies that address the underlying
causes of heart disease, today announced that company management
will participate in the SVB Securities Global Biopharma Conference
and Cowen’s 43rd Annual Health Care Conference. Details of
participation are as follows:
SVB Securities Global Biopharma ConferenceCompany
PresentationDate: February 16, 2023Time: 1:00 PM ET – 1:30 PM
ET
Cowen’s 43rd Annual Health Care ConferenceGenetic Medicines
PanelDate: March 6, 2023Time: 10:30 AM ET – 11:30 AM ET
A webcast of both events will be available by visiting the
Investors section of Tenaya’s website.
About Tenaya TherapeuticsTenaya
Therapeutics is a clinical-stage biotechnology company committed to
a bold mission: to discover, develop and deliver potentially
curative therapies that address the underlying drivers of heart
disease. Founded by leading cardiovascular scientists from
Gladstone Institutes and the University of Texas Southwestern
Medical Center, Tenaya is developing therapies for rare genetic
cardiovascular disorders, as well as for more prevalent heart
conditions, through three distinct but interrelated product
platforms: Gene Therapy, Cellular Regeneration and Precision
Medicine. For more information, visit
www.tenayatherapeutics.com.
Contacts
InvestorsMichelle CorralVice President,
Investor Relations and Corporate CommunicationsTenaya
TherapeuticsIR@tenayathera.com
MediaWendy RyanTen Bridge
Communicationswendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From May 2024 to Jun 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Jun 2023 to Jun 2024